Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profound Medical (PROF) Interest Expenses (2018 - 2024)

Profound Medical has reported Interest Expenses over the past 7 years, most recently at $128000.0 for Q3 2024.

  • For Q3 2024, Interest Expenses fell 35.35% year-over-year to $128000.0; the TTM value through Jun 2025 reached $128000.0, down 77.1%, while the annual FY2019 figure was $539026.7, 13.9% down from the prior year.
  • Interest Expenses for Q3 2024 was $128000.0 at Profound Medical, down from $181000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $543000.0 in Q4 2020 and troughed at $14000.0 in Q3 2022.
  • A 5-year average of $141752.1 and a median of $76000.0 in 2021 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: plummeted 95.56% in 2021 and later soared 1314.29% in 2023.
  • Year by year, Interest Expenses stood at $543000.0 in 2020, then tumbled by 96.13% to $21000.0 in 2021, then crashed by 33.33% to $14000.0 in 2022, then soared by 1314.29% to $198000.0 in 2023, then tumbled by 35.35% to $128000.0 in 2024.
  • Business Quant data shows Interest Expenses for PROF at $128000.0 in Q3 2024, $181000.0 in Q2 2024, and $180000.0 in Q1 2024.